Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

U.S. CDC backs previous advice for 5-day isolation; no test needed

Published 01/04/2022, 08:45 AM
Updated 01/05/2022, 06:05 PM
© Reuters. A member of the Ohio National Guard directs cars entering a testing site amid the coronavirus disease (COVID-19) pandemic, in Cleveland, Ohio, U.S., January 3, 2022.  REUTERS/Shannon Stapleton
DAL
-

By Susan Heavey and Doina Chiacu

WASHINGTON (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday backed its week-old guidance for people seeking to end their COVID-19 isolation at five days, adding they could take a rapid antigen test if they want to and can access one, but is not requiring that.

The agency had been pressured by health experts to institute a test requirement after it cut in half its guidance last week for people to isolate after a COVID-19 infection to 5 days from 10. It said the move was based on science around transmission of the virus.

On Tuesday, the CDC added an explanation on its website, saying that a review of 113 studies from 17 countries showed that most transmission occurs early in the course of infection. It said the average period of infectiousness and risk of transmission was "between 2-3 days before and 8 days after symptom onset."

Dr. Anthony Fauci, the nation's top infectious disease official and President Joe Biden's chief medical adviser, in television interviews on Sunday said officials were considering asking people to get tested after a five-day quarantine period.

The agency's new advice stops short of mandating or recommending the test.

"If an individual has access to a test and wants to test, the best approach is to use an antigen test towards the end of the 5-day isolation period," the agency said.

The isolation period should be followed by strict mask use for an additional five days, the CDC said last week and again on Tuesday. However, if an individual tests positive after 5 days, they should isolate for the full 10 days, it said.

The highly transmissible Omicron variant of the coronavirus has spread rapidly, leading to worker shortages at airlines, schools and businesses. Delta Airlines (NYSE:DAL) and others had publicly pressured the CDC to cut the isolation period. The CDC subsequently shortened the recommended isolation time.

Earlier on Tuesday, U.S. Surgeon General Vivek Murthy told CNN that the CDC had heard the complaints.

"They have certainly received feedback and questions about the role of testing in shortening that quarantine period and they're actually working right now on issuing a clarification on that," he said.

The policy is in line with comments CDC Director Rochelle Walensky made late on Monday.

If people have access to a rapid antigen test, they can go ahead and take it five days after testing positive if their symptoms are gone and they feel well, she told CBS' "The Late Show" program.

"If it's positive, stay home for another five days," she said.

© Reuters. A member of the Ohio National Guard directs cars entering a testing site amid the coronavirus disease (COVID-19) pandemic, in Cleveland, Ohio, U.S., January 3, 2022.  REUTERS/Shannon Stapleton

"If it's negative, I would say you still really need to wear a mask" because the infection could still spread, she added.

"You still should probably not visit grandma, you shouldn't get on an airplane and you still should be pretty careful when you're with other people."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.